Consonance Capital Partners (“CCP”) is a private equity manager focused exclusively on investing in the healthcare industry. CCP’s founders, Mitchell Blutt, MD, Benjamin Edmands, Stephen McKenna, and Nancy-Ann DeParle, partnered together for over a decade while at JPMorgan Partners and its successor and predecessor entities (collectively “JPMP”), and have over 90 years of combined experience in private equity investing, primarily within healthcare. To date, CCP has raised over $1.3 billion in equity capital across two funds, and CCP is currently investing out of Consonance Private Equity II, L.P. CCP targets growth equity, leveraged buyouts, and recapitalization transactions in the middle market. Target companies generally have between $25 million and $500 million in revenues. With a history of successfully investing across multiple healthcare sub-sectors, Consonance Capital Partners brings a wealth of experience, insights, and an extensive network of relationships to existing and prospective management teams and portfolio companies.
Company Details
- Employees
- 32
- Address
- 1370 Avenue Of The Americas,
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Keywords
- private equity, healthcare, growth equity.
- HQ
- New York, NY
Consonance Capital Partners Questions
Consonance Capital Partners's website is http://consonancecapitalpartners.com
Consonance Capital Partners's LinkedIn profile is https://www.linkedin.com/company/consonance-capital-partners
Consonance Capital Partners has
32 employees.
View email and phone details for 32
employees at Consonance Capital Partners.
Consonance Capital Partners's industry is
Venture Capital and Private Equity Principals
Consonance Capital Partners's top competitors are
Avesi Partners,
Suvretta Capital Management, Llc,
Peloton Equity,
Court Square Capital Partners,
Manatt, Phelps & Phillips, Llp,
Altaris, Llc,
Vss Capital Partners,
Consonance,
Veritas Capital,
Garnett Station Partners.
Consonance Capital Partners's categories are Venture Capital and Private Equity Principals
